Leap Therapeutics Inc. (LPTX)
0.32
0.00 (1.27%)
At close: Apr 11, 2025, 1:58 PM
13F Institute Ownership
Total Institutes of 59 in Leap Therapeutics reduced their positions with a decrease of 1 investors compared to the previous quarter. An additional 10.08M shares, as total invested capital declined by $262.7K with ownership percentage increasing from 28.79% to 33.00%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.209
0.21
Call Flow 21,500
83%
Put Flow 4,500
17%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 14.17% | 5.32M | +100.00% | 15.29M | 0.99% |
| Samsara Biocapital, LLC | 6.50% | 2.44M | +0.00% | 7.02M | 0.96% |
| Point72 Asset Management, L.p. | 3.73% | 1.4M | +100.00% | 4.03M | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.